GT-02001

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameGT-02001
Drug Alias NameGlyco-modified somatostatin;glycosylated somatostatinG-SRIF-28GT-02037
ClassificationBiologics
Mechanisms of ActionGrowth hormone releasing factor antagonistsSomatostatin receptor agonists
TargetsGrowth hormone releasing factorSomatostatin receptor
Therapy Area/IndicationsAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlytech IncNippon Shokubai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlytech IncFRONTEO IncNippon Shokubai Co Ltd
Active IndicationsN/A
Inactive IndicationsAcromegaly

Other Information

ATC CodeN/A
Related LinksN/A